rodents < role < roles

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 129.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000012 (2005)	Norihiro Nishimoto [Japon]	Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan
000014 (2012)	Seiji Ohtori [Japon] ; Masayuki Miyagi [Japon] ; Yawara Eguchi [Japon] ; Gen Inoue [Japon] ; Sumihisa Orita [Japon] ; Nobuyasu Ochiai [Japon] ; Shunji Kishida [Japon] ; Kazuki Kuniyoshi [Japon] ; Junichi Nakamura [Japon] ; Yasuchika Aoki [Japon] ; Tetsuhiro Ishikawa [Japon] ; Gen Arai [Japon] ; Hiroto Kamoda [Japon] ; Miyako Suzuki [Japon] ; Masashi Takaso [Japon] ; Takeo Furuya [Japon] ; Gou Kubota [Japon] ; Yoshihiro Sakuma [Japon] ; Yasuhiro Oikawa [Japon] ; Tomoaki Toyone [Japon] ; Kazuhisa Takahashi [Japon]	Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica
000024 (2012)	A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France]	Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?
000031 (2005)	Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon]	Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
000039 (2011)	Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]	Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000052 (2009)	Miho Suzuki [Japon] ; Misato Hashizume [Japon] ; Hiroto Yoshida [Japon] ; Masahiko Mihara [Japon]	Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
000058 (2014)	Lucie M. Turcotte [États-Unis] ; Colleen K. Correll ; Robyn C. Reed ; Christopher L. Moertel	Sustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance
000068 (2012)	Yee Chiu [Royaume-Uni] ; Andrew J. K. Ostor [Royaume-Uni] ; Anthony Hammond [Royaume-Uni] ; Katharina Sokoll [Royaume-Uni] ; Marina Anderson [Royaume-Uni] ; Maya Buch [Royaume-Uni] ; Michael R. Ehrenstein [Royaume-Uni] ; Patrick Gordon [Royaume-Uni] ; Sophia Steer [Royaume-Uni] ; Ian N. Bruce [Royaume-Uni]	Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales
000091 (2012)	Sooha Kim [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]	Interleukin-6 and cytochrome-P450, reason for concern?
000100 (2012)	K. Tenbrock [Allemagne]	Therapie der juvenilen idiopathischen Arthritis (JIA)
000113 (2005)	Josef S. Smolen [Autriche] ; Kurt Redlich [Autriche] ; Jochen Zwerina [Autriche] ; Daniel Aletaha [Autriche] ; Günter Steiner [Autriche] ; Georg Schett [Autriche]	Pro-inflammatory cytokines in rheumatoid arthritis
000122 (2006)	C. Christodoulou [Royaume-Uni] ; E. H. Choy [Royaume-Uni]	Joint inflammation and cytokine inhibition in rheumatoid arthritis
000125 (2012)	Nicolas Rohleder [États-Unis] ; Martin Aringer [Allemagne] ; Matthias Boentert [Allemagne]	Role of interleukin‐6 in stress, sleep, and fatigue
000131 (2010)	J. J. Leyden [États-Unis] ; H. Gollnick [Allemagne] ; D. Thiboutot [États-Unis] ; B. Dreno [France] ; V. Bettoli [Italie] ; S. Kang [États-Unis] ; A. Shalita [États-Unis] ; V. Torres	The hypothetical role of FoxO1 in acne is interesting, but more study is needed before any conclusions can be drawn
000141 (2011)	H. Bastian [Allemagne] ; E. Feist [Allemagne] ; G.-R. Burmester [Allemagne]	Therapiestrategien bei rheumatoider Arthritis
000143 (2012)	Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]	Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
000153 (2013)	Akiyuki Uzawa [Japon] ; Masahiro Mori [Japon] ; Satoshi Kuwabara [Japon]	Role of interleukin‐6 in the pathogenesis of neuromyelitis optica
000179 (2009)	Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto	Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody
000204 (2010)	C. J. Edwards [Royaume-Uni] ; E. Williams [Royaume-Uni]	The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis
000208 (2010)	Sook Kyung Chang [États-Unis] ; Zhizhan Gu [États-Unis] ; Michael B. Brenner [États-Unis]	Fibroblast‐like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin‐11
000209 (2013)	D. Ernst [Allemagne] ; R. E. Schmidt [Allemagne] ; T. Witte [Allemagne]	Sekundäre Immundefizienz bei rheumatologischen Erkrankungen

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "role" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "role" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    role
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021